How many AI projects in pharma generate excitement — but never generate results?

‍

The industry is flooded with pilots, proofs-of-concept, and ambitious roadmaps. Yet most organisations are still struggling to turn AI into measurable business value.

Why? Because successful AI adoption isn't about the technology alone. It's about solving real operational challenges with the right tool.

In this session, Benjamin Halphen (Head of Customer Solutions & Analytics, Biogen) walks through exactly how his team put Arcane, Anthill's AI-assisted content engine, to work — moving from brief to MLR-ready copy in a fraction of the usual time. Tor Kristensen (Chief Innovation Officer, Anthill) joins him to demo Arcane live and take questions from the audience.

No theory. No hype. Just a real Biogen case, four months into rollout.

In this session, you'll see:

• A detailed walkthrough of how Biogen uses Arcane to go from brief to full content, ready for MLR review
• How Biogen validated content quality and referencing at scale — straight from Benjamin
• Where AI is creating measurable value in pharma content today, and why many projects stall before they get there
• A live product demo of Arcane, plus audience Q&A with Anthill's Chief Innovation Officer

This isn't a highlight reel of theory — it's Benjamin's own team, sharing what changed once Arcane became part of their content process.